GSK3 inhibitors: development and therapeutic potential.
Cohen
Philip
P
MRC Protein Phosphorylation Unit, School of Life Sciences, University of Dundee, Dundee, DD1 5EH, UK. p.cohen@dundee.ac.uk
Goedert
Michel
M
D000818:Animals; D016503:Drug Delivery Systems / Q000379:methods; D015507:Drugs, Investigational / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use*; D038362:Glycogen Synthase Kinase 3 / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006801:Humans; D013678:Technology, Pharmaceutical / Q000379:methods*
D015507:Drugs, Investigational; D004791:Enzyme Inhibitors; D038362:Glycogen Synthase Kinase 3